2017-10736. Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals

AGENCY:

Food and Drug Administration, HHS.

ACTION:

Notice.

SUMMARY:

The Food and Drug Administration (FDA) is publishing a list of information collections that have been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995.

FOR FURTHER INFORMATION CONTACT:

Ila S. Mizrachi, Office of Operations, Food and Drug Administration, Three White Flint North, 11601 Landsdown Street, North Bethesda, MD 20852, 301-796-7726, [e-mail].

SUPPLEMENTARY INFORMATION:

The following is a list of FDA information collections recently approved by OMB under section 3507 of the Paperwork Reduction Act of 1995 (44 U.S.C. 3507). The OMB control number and expiration date of OMB approval for each information collection are shown in table 1. Copies of the supporting statements for the information collections are available on the Internet at https://www.reginfo.gov/​public/​do/​PRAMain. An Agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number.

Table 1—List of Information Collections Approved by OMB

Title of collection	OMB control No.	Date approval expires
Procedures for the Safe Processing and Importing of Fish and Fishery Products	0910-0354	2/29/2020
Biological Products: Reporting of Biological Product Deviations and Human Cells, Tissues, and Cellular and Tissue-Based Product Deviations; Form FDA 3486 and Addendum, 3486A	0910-0458	2/29/2020
Designation of New Animal Drugs for Minor Use or Minor Species	0910-0605	2/29/2020
Unique Device Identification System	0910-0720	2/29/2020
Animal Feed Regulatory Program Standards	0910-0760	2/29/2020
Premarket Approval of Medical Devices—21 CFR Part 814	0910-0231	3/31/2020
Human Tissue Intended for Transplantation	0910-0302	3/31/2020
General Licensing Provisions: Biological License Application, Changes to an Approved Application, Labeling, Revocation and Suspension, and Form FDA 356h	0910-0338	3/31/2020

Dated: May 18, 2017.

Anna K. Abram,

Deputy Commissioner for Policy, Planning, Legislative, and Analysis.